BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24887297)

  • 1. Polarity gene alterations in pure invasive micropapillary carcinomas of the breast.
    Gruel N; Benhamo V; Bhalshankar J; Popova T; Fréneaux P; Arnould L; Mariani O; Stern MH; Raynal V; Sastre-Garau X; Rouzier R; Delattre O; Vincent-Salomon A
    Breast Cancer Res; 2014 May; 16(3):R46. PubMed ID: 24887297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
    Maguire SL; Peck B; Wai PT; Campbell J; Barker H; Gulati A; Daley F; Vyse S; Huang P; Lord CJ; Farnie G; Brennan K; Natrajan R
    J Pathol; 2016 Nov; 240(3):315-328. PubMed ID: 27512948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma.
    Pareja F; Selenica P; Brown DN; Sebastiao APM; da Silva EM; Da Cruz Paula A; Del A; Fu L; Weigelt B; Brogi E; Reis-Filho JS; Wen HY
    Histopathology; 2019 Jul; 75(1):139-145. PubMed ID: 30843622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell polarity and cell adhesion associated gene expression differences between invasive micropapillary and no special type breast carcinomas and their prognostic significance.
    Kramer Z; Kenessey I; Gángó A; Lendvai G; Kulka J; Tőkés AM
    Sci Rep; 2021 Sep; 11(1):18484. PubMed ID: 34531452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer.
    Pang JB; Savas P; Fellowes AP; Mir Arnau G; Kader T; Vedururu R; Hewitt C; Takano EA; Byrne DJ; Choong DY; Millar EK; Lee CS; O'Toole SA; Lakhani SR; Cummings MC; Mann GB; Campbell IG; Dobrovic A; Loi S; Gorringe KL; Fox SB
    Mod Pathol; 2017 Jul; 30(7):952-963. PubMed ID: 28338653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIN7A is a major determinant of cell-polarity defects in breast carcinomas.
    Gruel N; Fuhrmann L; Lodillinsky C; Benhamo V; Mariani O; Cédenot A; Arnould L; Macgrogan G; Sastre-Garau X; Chavrier P; Delattre O; Vincent-Salomon A
    Breast Cancer Res; 2016 Feb; 18(1):23. PubMed ID: 26887652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep sequencing reveals small RNA characterization of invasive micropapillary carcinomas of the breast.
    Li S; Yang C; Zhai L; Zhang W; Yu J; Gu F; Lang R; Fan Y; Gong M; Zhang X; Fu L
    Breast Cancer Res Treat; 2012 Nov; 136(1):77-87. PubMed ID: 22976804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic and genomic characterization of papillary carcinomas of the breast.
    Duprez R; Wilkerson PM; Lacroix-Triki M; Lambros MB; MacKay A; A'Hern R; Gauthier A; Pawar V; Colombo PE; Daley F; Natrajan R; Ward E; MacGrogan G; Arbion F; Michenet P; Weigelt B; Vincent-Salomon A; Reis-Filho JS
    J Pathol; 2012 Feb; 226(3):427-441. PubMed ID: 22025283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma
    Pareja F; Brown DN; Lee JY; Da Cruz Paula A; Selenica P; Bi R; Geyer FC; Gazzo A; da Silva EM; Vahdatinia M; Stylianou AA; Ferrando L; Wen HY; Hicks JB; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2020 Jul; 26(14):3682-3693. PubMed ID: 32220886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and overexpression of PSCA at 8q24 in invasive micropapillary carcinoma of breast.
    Meng F; Liu B; Xie G; Song Y; Zheng X; Qian X; Li S; Jia H; Zhang X; Zhang L; Yang YL; Fu L
    Breast Cancer Res Treat; 2017 Nov; 166(2):383-392. PubMed ID: 28755148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma.
    Acs G; Esposito NN; Rakosy Z; Laronga C; Zhang PJ
    Am J Surg Pathol; 2010 Nov; 34(11):1637-46. PubMed ID: 20975342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathology of Micropapillary Carcinomas: Is Characteristic Morphology Related to Molecular Mechanisms?
    Sagnak Yilmaz Z; Sarioglu S
    Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):267-277. PubMed ID: 37036419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar prognoses for invasive micropapillary breast carcinoma and pure invasive ductal carcinoma: a retrospectively matched cohort study in China.
    Liu Y; Huang X; Bi R; Yang W; Shao Z
    PLoS One; 2014; 9(9):e106564. PubMed ID: 25188383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PSCA expression in invasive micropapillary carcinoma of breast].
    Hao JY; Yang YL; Li S; Qian XL; Liu FF; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):382-6. PubMed ID: 21914346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas.
    Ng CKY; Piscuoglio S; Geyer FC; Burke KA; Pareja F; Eberle CA; Lim RS; Natrajan R; Riaz N; Mariani O; Norton L; Vincent-Salomon A; Wen YH; Weigelt B; Reis-Filho JS
    Clin Cancer Res; 2017 Jul; 23(14):3859-3870. PubMed ID: 28153863
    [No Abstract]   [Full Text] [Related]  

  • 18. Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
    Lacroix-Triki M; Suarez PH; MacKay A; Lambros MB; Natrajan R; Savage K; Geyer FC; Weigelt B; Ashworth A; Reis-Filho JS
    J Pathol; 2010 Nov; 222(3):282-98. PubMed ID: 20815046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microscopic landscape of the invasive breast cancer genome.
    Ping Z; Xia Y; Shen T; Parekh V; Siegal GP; Eltoum IE; He J; Chen D; Deng M; Xi R; Shen D
    Sci Rep; 2016 Jun; 6():27545. PubMed ID: 27283966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive molecular portraits of human breast tumours.
    Cancer Genome Atlas Network
    Nature; 2012 Oct; 490(7418):61-70. PubMed ID: 23000897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.